Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Amber Tong
amber@endpointsnews.com
@AmberTongPW
Amber Tong on LinkedIn
author articles
Alexandria seals $143M deal in Seattle's 'heart of the heart,' grabbing coveted land to build its biotech cluster
6 years ago
Startups
FDA AdCom backs Gilead's move to expand Descovy label — but stops short of endorsing broad PrEP use
6 years ago
R&D
Pharma
Permira proposes to take Cambrex private in $2.4B deal, stirring up CDMO M&A
6 years ago
Deals
Outsourcing
Part procedure, part drug: Robert Ang joins Siddhartha Mukherjee in pioneering a new type of cell engineering
6 years ago
People
Startups
AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race
6 years ago
R&D
Pharma
Under a cloud of opioid lawsuits, Mallinckrodt suspends specialty generics spinoff
6 years ago
Deals
FDA endorses Novavax's pivotal trial design for flu vaccine; Forty Seven bags funding for myelodysplastic syndromes ...
6 years ago
News Briefing
Neoleukin's quest to shake up the IL-2 space gets a boost via reverse merger with Aquinox
6 years ago
Deals
Takeda kicks up GPCR work with Sosei Heptares, dishing out $26M to get GI drug discovery going
6 years ago
Deals
Daiichi Sankyo scores landmark FDA OK for rare tumor drug — albeit with restrictions
6 years ago
Pharma
David Apelian to steer TCR play at Pitt spinout; Third Rock scoops Illumina exec as CEO of cancer detection upstart
6 years ago
Peer Review
Move over, Hong Kong: Shanghai’s new tech board sees fervent demand for maiden biotech IPO
6 years ago
Financing
China
At newly rechristened Rakuten Medical, Japanese billionaire Mikitani ups the ante with another megaround
6 years ago
Financing
Adrian Hayday refutes challenge on influential autoantibody paper by Karolinska scientists
6 years ago
Discovery
Fresh delay for $4.3B Roche/Spark deal triggers analyst concerns about gene therapy M&A
6 years ago
Deals
Approval in sight, Perceptive, OrbiMed double down on Foamix's antibiotic foam to the tune of $64M
6 years ago
Financing
Verastem taps board director and Eli Lilly vet Brian Stuglik to right the commercial boat
6 years ago
People
Strapped for cash, Woodford's unraveling continues as listed fund considers kicking him out as manager
6 years ago
People
Wellcome Trust joins warning for no-deal Brexit, calls on Boris Johnson to cast R&D vision
6 years ago
People
Discovery
Laser-focused on colorectal cancer test, Freenome wins $160M from marquee VC pack led by RA, Polaris
6 years ago
Financing
Startups
Novartis backs Harvard spinout's quest to build TCR repository in $48M round
6 years ago
Financing
Startups
FDA OKs Humira copycat from Merck, Samsung Bioepis — but they will wait 4 years to launch
6 years ago
Pharma
Proteostasis shakes up medical team; Novo funds antibiotics efforts out of Curza, Spero
6 years ago
News Briefing
PACT Pharma says it's perfected the tech to select neoantigens for personalized therapy — now onto the clinic
6 years ago
Discovery
Cell/Gene Tx
First page
Previous page
93
94
95
96
97
98
99
Next page
Last page